Particle Data Platform

Rethinking Mood Treatments

35:1235:52 · 40s

While SSRIs remain standard for PMDD, Rubin argues immune pathways may be driving symptoms for some women, raising the case to explore antihistamine combinations and new therapies.

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click "Accept All" to consent, or "Decline non-essential" to opt out of non-essential cookies. Read our Privacy Policy.